VIVEbiotech Strengthens Its Presence in Asia in 2026
Building on its established footprint in the region, the company reinforces participation in key biotech events across one of the world’s most dynamic cell and gene therapy ecosystems.
Asia continues to be one of the most dynamic biotech regions worldwide, and in 2026 its momentum matters more than ever. In this context, VIVEbiotech is building on its established presence across the region, strengthening collaborations, expanding its footprint and supporting what its innovation can contribute to the global CGT landscape.
Throughout 2026, VIVEbiotech will also participate in two major regional events: BIO KOREA in Seoul and BioJapan in Yokohama—both key hubs for scientific exchange, partnership development and new opportunities in advanced therapies.
Maintaining and expanding activity in Asia enables VIVEbiotech to stay closely connected to a rapidly evolving ecosystem, engage with emerging collaborators and further consolidate its international presence.
If you would like to watch the full video, you can click here.